ArticleFrontiers in oncology2022

Clinical implications of the tumor microenvironment using multiplexed immunohistochemistry in patients with advanced or metastatic renal cell carcinoma treated with nivolumab plus ipilimumab.

Jwa Hoon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.